Untargeted Metabolic Profiling of Cat Urine and Plasma in Hypertension

Jim Scott-Baumann1, Alice H Watson2, Luis Mur1

  • 1Aberystwyth University, Faculty of Earth and Life Sciences, Aberystwyth School of Veterinary Sciences, Aberystwyth, Wales, United Kingdom of Great Britain and Northern Ireland.

Insights

This study used untargeted metabolomics to find new biomarkers for feline hypertension. Altered metabolites in hypertensive cats show similarities to those found in other species, aiding in understanding the disease.

Area of Science:

  • Veterinary Medicine
  • Metabolomics
  • Biochemistry

Background:

  • Early diagnosis of feline hypertension is challenging due to lack of routine screening and potential for white coat artifact.
  • Identifying novel biomarkers through metabolomic analysis can improve understanding of hypertension pathogenesis in cats.
  • Less sensitive diagnostic tests for short-term blood pressure changes are needed.

Purpose of the Study:

  • To identify biochemical differences in cat plasma and urine using untargeted metabolomics.
  • To compare normotensive controls (NT) with pre-treatment hypertensive cats (HTpre) and treated hypertensive cats (HTtx).

Main Methods:

  • Utilized biobanked plasma and urine samples from client-owned cats aged over 9 years.
  • Employed flow infusion electrospray-high-resolution mass spectrometry for sample profiling.
  • Analyzed data using univariate and multivariate statistical methods via MetaboAnalyst, with metabolite identification using MZedDb.

Main Results:

  • Significant biochemical differences were detected between normotensive, pre-treatment hypertensive, and treated hypertensive cats.
  • Urine metabolite changes in pre-treatment hypertensive cats were associated with the tricarboxylic acid cycle, oxidative stress, steroid hormones, taurine metabolism, and phosphatidylinositol-3,4,5-trisphosphate.
  • Identified specific metabolic pathways and compounds altered in feline hypertension.

Conclusions:

  • Metabolic alterations observed in hypertensive cats share similarities with those found in other species.
  • These findings contribute to the understanding of feline hypertension's biochemical underpinnings.
  • Suggests potential for metabolomics in developing new diagnostic approaches for feline hypertension.
Abstract